Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
317 hedge funds and large institutions have $3.48B invested in Amedisys in 2019 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 117 increasing their positions, 107 reducing their positions, and 43 closing their positions.
49% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 43
7% more funds holding
Funds holding: 297 → 317 (+20)
9% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 107
3.88% less ownership
Funds ownership: 92.17% → 88.3% (-3.9%)
27% less capital inflows, than outflows
Capital inflows: $353M | Capital outflows: $486M
61% less call options, than puts
Call options by funds: $10.3M | Put options by funds: $26.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
+$22.4M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$20.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.7M |
| 4 |
AJO LP
Philadelphia,
Pennsylvania
|
+$13.4M |
| 5 |
Two Sigma Advisers
New York
|
+$12.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$104M |
| 2 |
TimesSquare Capital Management
New York
|
-$33.9M |
| 3 |
Laurion Capital Management
New York
|
-$31M |
| 4 |
Morgan Stanley
New York
|
-$28.9M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$16.2M |
AMED Hedge Fund Activity: Q1 2019 in Review
317 of the 4,634 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2019, worth a combined $3.48B — up 1.2% from $3.44B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new AMED positions and 43 closed out — a net gain of 21 holders — while 117 added to existing stakes and 107 trimmed.
The largest buyer was Man Group, adding an estimated $22.4M. The largest seller was BlackRock, cutting an estimated $104M.
- 317 institutional investors held Amedisys (AMED) as of Q1 2019, up from 297 in Q4 2018.
- Funds reported $3.48B of Amedisys stock for Q1 2019, up 1.2% quarter-over-quarter.
- 64 funds opened new Amedisys positions in Q1 2019 and 43 closed out, a net change of +21 holders.
- The largest Amedisys buyer in Q1 2019 was Man Group, an estimated $22.4M added.
- The largest Amedisys seller in Q1 2019 was BlackRock, an estimated $104M sold.
Based on aggregated 13F filings for Q1 2019.